Effects of over- and under-expression of Cu,Zn-superoxide dismutase on the toxicity of glutamate analogs in transgenic mouse striatum

Brain Research

Volumn 789, Issue 1, 1998, Pages 32-39

  Schwartz, Paul J ^a,b   Reaume, Andrew ^c   Scott, Richard ^c   Coyle, Joseph T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CEPHALON INC   (United States)

Author keywords

Excitotoxicity; Glutamate toxicity; Oxidative stress; Superoxide dismutase

Indexed keywords

SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CORPUS STRIATUM; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CORPUS STRIATUM; GLUTAMATES; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 0032489979     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01469-8     Document Type: Article

References (49)

1. Bar-Peled O., Korkotian E., Segal M., Groner Y. Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic- Cu/Zn superoxide dismutase neurons. Proc. Natl. Acad. Sci. USA. 93:1996;8530-8535.
2. Beal M.F., Ferrante R.J., Henshaw R., Matthews R.T., Chan P.H., Kowall N.W., Epstein C.J., Schulz J.B. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 65:1995;919-922.
3. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical formation by peroxynitrate: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
4. Beckman J.S., Carson M., Smith C.D., Koppenol W.H. ALS, SOD and peroxynitrite. Nature. 364:1993;584.
5. Beckman J.S., Chen J., Crow J.P., Ye Y.Z. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog. Brain Res. 103:1994;371-380.
6. Beckman J.S., Ischiropoulos H., Zhu L., van der Woerd M., Smith C., Chen J., Harrison J., Martin J.C., Tsai M. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch. Biochem. Biophys. 298:1992;438-445.
7. Bowler C., Slooten L., Vandenbranden S., De Rycke R., Botterman J., Sybesma C., Van Montagu M., Inze D. Manganese superoxide dismutase can reduce cellular damage mediated by oxygen radicals in transgenic plants. EMBO J. 10:1991;1723-1732.
8. Bristol L.A., Rothstein J.D. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann. Neurol. 39:1996;676-679.
9. Bruijn L.I., Beal M.F., Becher M.W., Schulz J.B., Wong P.C., Price D.L., Cleveland D.W. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA. 94:1997;7606-7611.
10. Bull G., Oderfeld-Nowak B. Standardization of a radiochemical assay of choline acetyltransferase and a study of the activation of the enzyme in rabbit brain. J. Neurochem. 19:1971;935-947.
11. Cadet J.L., Ladenheim B., Baum I., Carlson E., Epstein C. CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). Brain Res. 655:1994;259-262.
12. Cadet J.L., Sheng P., Ali S., Rothman R., Carlson E., Epstein C. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62:1994;380-383.
13. 3 extraction prior to nissl staining. Stain Tech. 44:1969;207-208.
14. Chan P.H., Chu L., Chen S.F., Carlson E.J., Epstein C.J. Attenuation of glutamate-induced neuronal swelling and toxicity in transgenic mice overexpressing human CuZn-superoxide dismutase. Acta Neurochim. Suppl. 51:1990;245-247.
15. Chan P.H., Chu L., Chen S.F., Carlson E.J., Epstein C.J. Reduced neurotoxicity in transgenic mice overexpressing human copper-zinc-superoxide dismutase. Stroke. 21:1990;80-82.
16. Chan P.H., Kamii H., Yang G., Gafni J., Epstein C.J., Carlson E., Reola L. Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. Neuroreport. 5:1993;293-296.
17. Coyle J.T., Oster-Granite M.L., Reeves R.H., Gearhart J.D. Down syndrome, Alzheimer's disease and the trisomy 16 mouse. TINS. 11:1988;390-394.
18. Dawson V.D., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
19. de Haan J.B., Cristiano F., Iannello R., Bladier C., Kelner M.J., Kola I. Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Hum. Mol. Genet. 5:1996;283-292.
20. Elroy-Stein O., Groner Y. Impaired neurotransmitter uptake in PC12 cells overexpressing human Cu/Zn-superoxide dismutase - implication for gene dosage effects in Down syndrome. Cell. 52:1988;259-267.
21. Epstein C.J., Avraham K.B., Lovett M., Smith S., Elroy-Stein O., Rotman G., Bry C., Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA. 84:1987;8044-8048.
22. Farinelli S.E., Park D.S., Greene L.A. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J. Neurosci. 16:1996;2325-2334.
23. Flohé L., Ötting F. Superoxide dismutase assays. Methods Enzymol. 105:1984;93-104.
24. I. Fridovich, The biology of oxygen radicals: general concepts, in: B. Halliwell (Ed.), Oxygen Radicals and Tissue Injury, Proceedings of an Upjohn Symposium, FASEB, Bethesda, 1988, pp. 1-8.
25. Fridovich I. Superoxide dismutases. An adaptation to a paramagnetic gas. J. Biol. Chem. 264:1989;7761-7764.
26. 3H]dopa in various regions of the brain. J. Neurochem. 13:1966;655-669.
27. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
28. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J.C., Smith C.D., Beckman J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298:1992;431-437.
29. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
30. Kato K., Puttfarcken P.S., Lyons W.E., Coyle J.T. Developmental time course and ionic dependence of kainate-mediated toxicity in rat cerebellar granule cell cultures. J. Pharmacol. Exp. Ther. 256:1991;402-411.
31. Lai M., Griffiths H., Pall H., Williams A., Lunec J. An investigation into the role of reactive oxygen species in the mechanism of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine toxicity using neuronal cell lines. Biochem. Pharmacol. 45:1993;927-933.
32. Minc-Golomb D., Knobler H., Groner Y. Gene dosage of CuZn-SOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice. EMBO J. 10:1991;2119-2124.
33. Miyamoto M., Coyle J.T. Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins. Exp. Neurol. 108:1990;38-45.
34. Miyamoto M., Murphy T.H., Schnaar R.L., Coyle J.T. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 250:1989;1132-1140.
35. Murphy T.H., Schnaar R.L., Coyle J.T. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 4:1990;1624-1633.
36. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
37. Przedborski S., Kostic V., Jackson L.V., Naini A.B., Simonetti S., Fahn S., Carlson E., Epstein C.J., Cadet J.L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12:1992;1658-1667.
38. Puttfarcken P.S., Getz R.L., Coyle J.T. Kainic acid-induced lipid peroxidation: protection with butylated hydroxytoluene and U78517F in primary cultures of cerebellar granule cells. Brain Res. 624:1993;223-232.
39. Rader R.K., Lanthorn T.H. Experimental ischemia induces a persistent depolarization blocked by decreased calcium and NMDA antagonists. Neurosci. Lett. 99:1989;125-130.
40. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., Wilcox H.M., Flood D.G., Beal M.F., Brown R.H. Jr., Scott R.W., Snider W.D. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13:1996;43-47.
41. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R., Halperin J.J., Herzfeldt B., Van den Bergh R., Hung W., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., Brown R.H. Jr. Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
42. Schulz J.B., Matthews R.T., Jenkins B.G., Ferrante R.J., Siwek D., Henshaw D.R., Cipolloni P.B., Mecocci P., Kowall N.W., Rosen B.R., Beal M.F. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15:1995;8419-8429.
43. Schwartz P.J., Berger U.V., Coyle J.T. Mice transgenic for copper/zinc superoxide dismutase exhibit increased markers of biogenic amine function. J. Neurochem. 65:1995;660-669.
44. Torii H., Yoshida K., Kobayashi T., Tsukamoto T., Tanayama S. Disposition of idebenone (CV-2619), a new cerebral metabolism improving agent, in rats and dogs. J. Phamacol.-Dynam. 8:1985;457-467.
45. B.D. Watson, M.D. Ginsberg, Mechanisms of lipid peroxidation potentiated by ischemia in brain. In: B. Halliwell (Ed.), Oxygen Radicals and Tissue Injury: Proceedings of an Upjohn Symposium, FASEB, Bethesda, 1988, pp. 81-91.
46. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Row J.A., Lee M.K., Valentine J.S., Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:1996;515-518.
47. Wilson S.H., Schrier B.K., Farber J.L., Tompson E.J., Rosenberg R.N., Blume A.J., Nirenberg M.W. Markers for gene expression in cultured cells from nervous system. J. Biol. Chem. 247:1972;3159-3160.
48. Wood P.L., Rao T.S. A review of in vivo modulation of cerebellar cGMP levels by excitatory amino acid receptors: role of NMDA, quisqualate and kainate subtypes. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 15:1991;229-235.
49. Yang G., Chan P.H., Chen J., Carlson E., Chen S.F., Weinstein P., Epstein C.J., Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 25:1994;165-170.